We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Takes Risk-Management Approach to Initial Human Trials in Revised Guidelines
EMA Takes Risk-Management Approach to Initial Human Trials in Revised Guidelines
The European Medicines Agency broadened the scope of its first-in-human trials guidelines, accounting for advancements in clinical trials protocols and complex dose-escalation studies.